June 7, 2021

EuropaBio invited healthcare biotech SMEs to learn about EU Policy Priorities

June 7, 2021

Pragmatic IP solutions and strong collaborations will ensure faster global access to vaccines

May 31, 2021

EuropaBio Key Messages to 94th Pharmaceutical Committee – 28 May 2021

May 27, 2021

EuropaBio welcomes the EU strategy on Covid-19 therapeutics

May 27, 2021

EuropaBio meets EMA to exchange views on topics of common interest

2021_05_H_O_EMA-EuropaBio bilateral meeting_Agenda items 1 & 2 2021_05_H_O_EMA-EuropaBio bilateral meeting_Agenda items 4 & 5
May 25, 2021

Alliance for Regenerative Medicine, European Federation of Pharmaceutical Industries and Associations, and European Association for Bioindustries Call for Advanced Therapies to be Exempt from EU GMO Legislation

EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
May 20, 2021

EuropaBio Patient BioForum: Advancing Patient Access to Innovative Treatments

May 20, 2021

Decentralised clinical trials, the future of clinical research

The COVID-19 pandemic has been a catalyst for change which has led us to revisit the way we conduct clinical trials.
May 20, 2021

Advanced Therapies bring tranformational value to European patients

May 18, 2021

Interview with Bill Nankervis, Executive Vice President and Chief Operating Officer, Lallemand Group of Companies

EuropaBio sat down with new Member Lallemand, to find out what fires them up for the future of industrial biotechnology.
May 18, 2021

Lallemand joins EuropaBio: new global opportunities for industrial biotechnology

EuropaBio is pleased to announce that Lallemand has joined the organization as a corporate member.
May 12, 2021

Meatable joins EuropaBio: together towards a more sustainable food industry

EuropaBio is pleased to announce that Meatable has joined the organization as an associate member.
May 12, 2021

Interview with… Krijn de Nood, Co-Founder & CEO at Meatable

EuropaBio sat down with new Member Meatable, to find out about their journey from creation in 2018.
May 7, 2021

IP waiver for COVID-19 vaccines is a misguided and ineffective response to a shared global challenge

2021_05_H_PR_Waiver of Intellectual Property Rights for COVID-19 Vaccines – EuropaBio’s Position
May 4, 2021

Interview with… Juan Medina, Co-Founder & CEO at Kaffe Bueno

EuropaBio sat down with new corporate member Kaffe Bueno, to find out more about the future of coffee.
Become a member